Progen abandons PI-88
23 July, 2008 by Dylan Bushell-Embling and Kate McDonaldMassive share price plunge as Progen abandons lead compound trial
Pfizer Fellowships close soon
23 July, 2008 by Staff WritersApplications for the Pfizer Australia Research Fellowships close on Monday
Biotech summit approaches
23 July, 2008 by Staff WritersThe annual Australian Biotechnology Summit begins next week
Smooth sailing for NeuroDiscovery
22 July, 2008 by Staff WritersPhase I trial of neuropathic pain candidate successful
$45 billion for Genentech
22 July, 2008 by Kate McDonaldRoche offers to buy out remaining Genentech shares for A$45 billion
Biota and GSK kiss and make up
21 July, 2008 by Kate McDonaldMediation and $20 million allows Biota and GSK to conclude litigation over Relenza
Deloitte finalises Recom buy
18 July, 2008 by Kate McDonaldDeloitte completes acquisition of Recombinant Capital
Virosome studied by MedImmune
18 July, 2008 by Dylan Bushell-EmblingNorwood Abbey subsidiary's technology to be evaluated by MedImmune
HalcyGen works on IND
18 July, 2008 by Dylan Bushell-EmblingHalcyGen completes recruitment for SUBA-Itraconazole trial
Mesoblast's long-term protection
16 July, 2008 by Dylan Bushell-EmblingMesoblast awarded extended patent for MPC stem cells
Fun for Avita
16 July, 2008 by Dylan Bushell-EmblingFunhaler sales up, CellSpray still on the shelf
Neuren thinks big
16 July, 2008 by Dylan Bushell-EmblingNeuren completes recruitment for Phase III trials for cognitive impairment
More interest in Biosignal
15 July, 2008 by Dylan Bushell-EmblingBiosignal's anti-corrosion treatment under evaluation from ConocoPhillips
Unitract rolls out
15 July, 2008 by Dylan Bushell-EmblingUnilife commences sales of Unitract 1mL safety syringes
Circadian swallows Vegenics
15 July, 2008 by Dylan Bushell-EmblingCircadian is to trade shares for the remaining third of Vegenics
